Results 211 to 220 of about 3,377,180 (268)

Glucose-Dependent Insulinotropic Polypeptide Inhibits AGE-Induced NADPH Oxidase-Derived Oxidative Stress Generation and Foam Cell Formation in Macrophages Partly via AMPK Activation. [PDF]

Int J Mol Sci
Terasaki M, Yashima H, Mori Y, Saito T, Inoue N, Matsui T, Osaka N, Fujikawa T, Ohara M, Yamagishi SI.   +9 more
europepmc   +1 more source

Skeletal Muscle Mass and Body Weight Fall Proportionally With Use of Dual Glucagon-Like Peptide 1/Glucose-Dependent Insulinotropic Polypeptide Receptor Agonist Tirzepatide: Case Report and Review of Literature. [PDF]

AACE Clin Case Rep
Zinn J, Poretsky L.
europepmc   +1 more source

The Road towards Triple Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Glucagon Receptor - An Update. [PDF]

Endocrinol Metab (Seoul)
Jakubowska A, Roux CWL, Viljoen A.
europepmc   +1 more source

The association between glucose-dependent insulinotropic polypeptide and/or glucagon-like peptide-1 receptor agonist prescriptions and substance-related outcomes in patients with opioid and alcohol use disorders: A real-world data analysis. [PDF]

Addiction
Qeadan F, McCunn A, Tingey B.
europepmc   +1 more source

A Case Report of Systemic Allergic Reaction to the Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonist Tirzepatide. [PDF]

Cureus
Le TTB, Minh LHN, Devi P, Islam N, Sachmechi I.   +4 more
europepmc   +1 more source

Evaluating glucose-dependent insulinotropic polypeptide and glucagon as key regulators of insulin secretion in the pancreatic islet.

Am J Physiol Endocrinol Metab
Lewandowski SL, El K, Campbell JE.
europepmc   +1 more source

Effect of Dual Glucagon-Like Peptide 1/Glucose-Dependent Insulinotropic Polypeptide Receptor Agonist (Tirzepatide) versus Bariatric Surgery on Weight Loss and Nonalcoholic Fatty Liver Disease. [PDF]

Med Princ Pract
Al-Sabah S, Al-Khairi I, Jamal M, Jamal M, Qaddoumi M, Alajmi F, Kumar J, Abukhalaf N, Cherian P, Madhu D, Arefanian H, Dsouza C, Alam-Eldin N, AlSabagh A, Al Madhoun A, Al-Sabah S, Al-Mulla F, Abu-Farha M, Abubaker J.   +18 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Evolutionary expression of glucose-dependent-insulinotropic polypeptide (GIP)

Regulatory Peptides, 2011
Glucose-dependent insulinotropic polypeptide (GIP) is a mammalian incretin hormone released into the circulation following nutrient ingestion. We examined the functional evolution of GIP and its relationship with insulin to delineate their respective roles in promoting nutrient efficiency.
John Finnerty, Lisa I Jepeal
exaly   +3 more sources